Results of studies on a novel agent to treat multiple myeloma and a combination therapy aimed at slowing the progression of a precursor myeloma condition are among reports being presented by Dana-Farber Cancer Institute investigators at the 61st American Society of Hematology (ASH) Annual Meeting. The results are being presented by scientists in the Jerome Lipper Multiple Myeloma Center and the LeBow Institute for Myeloma Therapeutics at Dana-Farber.
Read More
>>Hollywood's Exotic Secret For Healthy Weight Loss
0 Response to "Scientists present promising findings in multiple myeloma at ASH Annual Meeting"
Post a Comment